<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJU</journal-id><journal-title-group><journal-title>Open Journal of Urology</journal-title></journal-title-group><issn pub-type="epub">2160-5440</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oju.2022.121008</article-id><article-id pub-id-type="publisher-id">OJU-114808</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Laparoscopic Pyelolithotomy: Initial Experience with 62 Patients
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cyril</surname><given-names>Kamadjou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Annie</surname><given-names>Kameni</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dolly</surname><given-names>Bilonda Kolela</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bertin</surname><given-names>Njinou Ngninkeu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fru</surname><given-names>Angwafor</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Medical and Surgical Center of Urology, Douala, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Surgery and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Coordinator Urology Residency Program, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>01</month><year>2022</year></pub-date><volume>12</volume><issue>01</issue><fpage>74</fpage><lpage>82</lpage><history><date date-type="received"><day>17,</day>	<month>December</month>	<year>2021</year></date><date date-type="rev-recd"><day>21,</day>	<month>January</month>	<year>2022</year>	</date><date date-type="accepted"><day>24,</day>	<month>January</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: To evaluate the role of the laparoscopic approach in the management of pelvic calculi in a urology centre in Douala, Cameroon. 
  Materials and Methods: This was a retrospective study carried out from 2014 to 2019 involving 62 patients with calculi at the renal pelvis managed through laparoscopic pyelolithotomy. 
  Results: We recruited 62 patients (38 men and 24 women) with a median age of 36 [25 - 48] years. Nephritic colic was the most frequently encountered presenting complaint (92% of cases). In 56.45% of cases, the stone was on the left side of the body. Twelve patients had kidney acute failure at the time of diagnosis. Five patients received antibiotics for urinary tract infections before the operation. Before surgery, eight double J stents were placed in 8 patients; in five because of urinary tract infection and in three because of nephritic colic. In all the cases, the definitive diagnosis was made using abdominal CT scans. The median size of the calculi was 22 [17 - 28] mm. Dilatation of the pyelocaliceal cavity was noticed in all the patients. The median surgery duration was 100 [90 - 120] minutes. Drainage of the urinary tract using a double J stent was performed in all the patients, whereas percutaneous drainage was performed only in 9.67% of cases. There was no case of conversion to open surgery. Control ultrasound performed one month after the removal of the double J stent did not reveal any residual stones in the pyelocaliceal cavities. 
  Conclusion: Laparoscopic pyelolithotomy is a mini-invasive technique that is adequate for the management of voluminous pelvic calculi.
 
</p></abstract><kwd-group><kwd>Laparoscopic Pyelolithotomy</kwd><kwd> Pelvic Calculi</kwd><kwd> Cameroon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Different surgical techniques have been established for the management of different types of kidney stones, and the choice of a technique depends on stone location and distribution. These techniques include non-invasive and minimally invasive modalities such as ureteroscopy (URS), extracorporeal shockwave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), laparoscopy, and robotic surgery [<xref ref-type="bibr" rid="scirp.114808-ref1">1</xref>]. Where non-invasive or minimally invasive methods are either unavailable or fail, invasive procedures (including open surgery) can be employed. The American Urological Association (AUA) recommends watchful waiting for patients with uncomplicated ureteral stones with sizes ≤ 10 mm, URS for patients with mid- or distal ureteral stones who require intervention and for patients with suspected cystine or uric acid ureteral stones in whom medical expulsive therapy (MET) as a treatment modality for adult patients with ureteral stones fails. In the case of adult patients with renal stones, the AUA recommends ESWL or URS for symptomatic patients with a total non-lower pole renal stone burden &lt; 20 mm and PCNL for symptomatic patients with a total renal stone burden &gt;20 mm [<xref ref-type="bibr" rid="scirp.114808-ref1">1</xref>]. Laparoscopic pyelolithotomy (LPL) is an important alternative to percutaneous nephrolithotomy (PCNL) in the management of large (≥20 mm) renal calculi; however, the latter technique remains the gold standard [<xref ref-type="bibr" rid="scirp.114808-ref2">2</xref>]. LPL is usually considered in patients who have renal anomalies, are poorly compliant, and have a large single renal-pelvic calculus [<xref ref-type="bibr" rid="scirp.114808-ref3">3</xref>]. LPL could follow a transperitoneal or retroperitoneal approach, and is usually performed under general anaesthesia. The transperitoneal approach involves insufflating the abdomen with carbon dioxide and making several small abdominal incisions. In the retroperitoneal approach, a small incision is made in the back and a dissecting balloon is inserted to create a retroperitoneal space. The stone is accessed through an incision in the renal pelvis (pyelotomy). Once the stone is removed, the pyelotomy incision is usually closed using sutures, with or without a stent [<xref ref-type="bibr" rid="scirp.114808-ref4">4</xref>]. LPL, like any other surgical procedure, is prone to complications. Potential complications of this technique are either associated with the removal of the stone or with the closure of the pyelotomy incision [<xref ref-type="bibr" rid="scirp.114808-ref5">5</xref>]. When laparoscopic pyeloplasty with concomitant pyelolithotomy was performed on 15 patients, all of them experienced wall oedema and friability due to fluid irrigation. Also, in a series involving 16 patients who underwent laparoscopic transperitoneal pyelolithotomy as the first-line treatment for pelvic stones published by Meria et al., 14 of the 16 patients had urinary leakage as a complication [<xref ref-type="bibr" rid="scirp.114808-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.114808-ref7">7</xref>]. This technique is more commonly used in developed countries, and the procedure has even been described in great detail [<xref ref-type="bibr" rid="scirp.114808-ref8">8</xref>]. However, despite all the advantages of these laparoscopic techniques, they are far from being common practice in resource-limited settings like ours, which explains the paucity of studies on this topic in such settings. Thus, we carried out this study that aimed to evaluate the role of the laparoscopic approach in the management of pelvic calculi at the Centre medico-chirugicaled’urologie in Douala, Cameroon.</p></sec><sec id="s2"><title>2. Methods and Materials</title><sec id="s2_1"><title>2.1. Study Design and Study Participants</title><p>This was a retrospective study over a period of six years (from January 2014 to December 2019) at the Centre medico-chirugicaled’ urologie, which is located in Bali, Douala. We consulted the clinical records of 62 patients with calculi at the renal pelvis who were treated through laparoscopic pyelolithotomy. We excluded patients with incomplete clinical records. Using pre-tested questionnaires, we collected data on patients’ ages, genders, clinical profiles, relevant medical history, sizes of the calculi, localisation of the calculi as confirmed by imaging, and outcome of lithotripsy. All patients underwent abdominopelvic CT before the procedure to localise the stones, and they all had at least one ureteric stone (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s2_2"><title>2.2. Pre-Operative and Intraoperative Procedures</title><p>All patients also consulted an anaesthesiologist anddida pre-operative workup, which included a full blood count, urea and creatinine, clotting profile, and urine analysis with culture and antibiotic susceptibility profiling. Those with confirmed urinary tract infections prior to the intervention were treated as per the results of culture and antibiotic susceptibility profiles. A second-generation cephalosporin was administered to all patients without confirmed urinary tract infections as a prophylactic antibiotic. All surgical procedures were performed under general anaesthesia. The patients were placed in the lateral position and the renal pelvis accessed transperitoneally. After inserting the abdominal trocars, pneumoperitoneum was achieved, and the kidney or ureter was exposed. The renal pelvis and ureter were identified, dissected, and opened. The stones were extracted using rigid laparoscopic forceps. The renal pelvis and ureter were sutured following the placement of an antegrade ureteral double J stent. The stones were then removed from the peritoneal cavity. In six patients, the procedure ended with the placement of an intraperitoneal drain. All the 62 participants were operated upon by the same two surgeons. Using the visual analogue scale (VAS), we classified the pain felt by the patients into either mild (VAS score &lt; 4), moderate (VAS score ranging from 4 to 8), or severe (VAS score &gt; 8).</p></sec><sec id="s2_3"><title>2.3. Data Management</title><p>The data collected from patients’ clinical records were entered into Microsoft Excel 2016 and then exported to Epi info 7 for analysis. Continuous data are presented as mean values and standard deviations (for normally distributed data) and medians with interquartile ranges (for skewed data). On the other hand, categorical data are presented as frequencies and percentages.This study was approved by the institutional review board of the Faculty of Medicine and Pharmaceutical Sciences (FMPS) of the University of Douala and by the ethical committee of the Centre medico-chirugicale d’urologie in Douala, Cameroon. The requirement for patients’ informed consent was waived due to the retrospective nature of the study.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Of the 62 patients we recruited in our study, 24 (38.71%) were females and 38 (61.29%) were males. The ages of the patients ranged from 7 years to 66 years, with a median age of 36 [25 - 48] years. As concerns the initial clinical presentations of the patients, 52 (83.87%) patients presented with acute nephritic colic (ANC), 5 (8.06%) presented with acute nephritic colic and sepsis, 3 (4.84%) presented with abdominal pains, and 2 (3.23%) presented with haematuria. The stones were located on the left side of the body in 35 (56.45%) cases and on the right in 27 (43.55%) cases. Fifty-one (82.26%) patients experienced mild pain, 10 (16.13%) experienced moderate pain, while only one participant (1.61%) experienced severe pain. Data on the clinical presentations of the study participants can be seen in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>All the patients were hospitalised and underwent LPL, which was successful in all 62 patients (100% stone-free rate). Of the 62 patients, double J stents were placed preoperatively in 8 (12.9%) patients. Percutaneous drainage was also performed in 8 (12.9%) patients. Double J drainage was carried out in all 62 patients post-operatively. Complications occurred in 3 (4.84%) of our patients, who were all males; two (66.67%) of these complications were cases of colic, while one (33.33%) was a case of a fistula.</p><p>The duration of the mini-invasive procedure ranged from 60 minutes to200 minutes with a median duration of 100 [90 - 120] minutes). The duration of hospitalization of the patients ranged from 1 day to 5 days, with a mean duration of 2.21 &#177; 1.07 days. The estimated blood loss during the intervention ranged from 50 ml to 400 ml with a median estimated blood loss of 110 [80 - 150] ml. The duration for which the double J stent was left in place ranged from 6 days to 90 days, with a median duration of 18 [15 - 21] days. The drains were left in place for durations ranging from 0 days to 3 days. The drains were removed on day 0 for 55 (88.71%) participants, on day 1 for 1 (1.61%) participant, on day 2 for 5 (8.06%) participants, and on day 3 for 1 (1.61%) participant. The details of the surgical procedure and postoperative hospitalization of the study participants are presented in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>As for the paraclinical tests carried out, the imaging technique used to locate the stones in all 62 patients was the (anteroposterior) CT scan. All the stones were located in the renal pelvis. The sizes of the stones ranged from 14 mm to 37 mm, with a median stone size of 22 [17 - 28] mm. Urinalysis was performed in 5 (8.06%) of the participants. Regarding culprit pathogens, no pathogen was identified in 57 (91.94%) cases. The culprit pathogens were Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in 1 (1.61%) case each, and it was</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical presentations of the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >VARIABLES</th><th align="center" valign="middle" >MALES (%)</th><th align="center" valign="middle" >FEMALES (%)</th><th align="center" valign="middle" >TOTAL (%)</th></tr></thead><tr><td align="center" valign="middle" >Clinical presentation</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Colic</td><td align="center" valign="middle" >34 (89.47)</td><td align="center" valign="middle" >18 (75)</td><td align="center" valign="middle" >52 (83.87)</td></tr><tr><td align="center" valign="middle" >Colic and sepsis</td><td align="center" valign="middle" >4 (10.53)</td><td align="center" valign="middle" >1 (4.17)</td><td align="center" valign="middle" >5 (8.06)</td></tr><tr><td align="center" valign="middle" >Abdominal pain</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >3 (12.5)</td><td align="center" valign="middle" >3 (4.84)</td></tr><tr><td align="center" valign="middle" >Haematuria</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >2 (8.33)</td><td align="center" valign="middle" >2 (3.23)</td></tr><tr><td align="center" valign="middle" >Laterality</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >22 (57.89)</td><td align="center" valign="middle" >13 (54.17)</td><td align="center" valign="middle" >35 (56.45)</td></tr><tr><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >16 (42.11)</td><td align="center" valign="middle" >11 (45.83)</td><td align="center" valign="middle" >27 (43.55)</td></tr><tr><td align="center" valign="middle" >Degree of pain (VAS)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mild</td><td align="center" valign="middle" >29 (76.32)</td><td align="center" valign="middle" >22 (91.67)</td><td align="center" valign="middle" >51 (82.26)</td></tr><tr><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >8 (21.05)</td><td align="center" valign="middle" >2 (8.33)</td><td align="center" valign="middle" >10 (16.13)</td></tr><tr><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >1 (1.61)</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Details of the surgical procedure and hospitalisation of the participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >VARIABLES</th><th align="center" valign="middle" >MALES (%)</th><th align="center" valign="middle" >FEMALES (%)</th><th align="center" valign="middle" >TOTAL (%)</th></tr></thead><tr><td align="center" valign="middle" >Pre-op double J</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >6 (15.79)</td><td align="center" valign="middle" >2 (8.33)</td><td align="center" valign="middle" >8 (12.90)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >32 (84.21)</td><td align="center" valign="middle" >22 (91.67)</td><td align="center" valign="middle" >54 (87.10)</td></tr><tr><td align="center" valign="middle" >Percutaneous drainage</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >7 (18.42)</td><td align="center" valign="middle" >1 (4.17)</td><td align="center" valign="middle" >8 (12.90)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >31 (81.58)</td><td align="center" valign="middle" >23 (95.83)</td><td align="center" valign="middle" >54 (87.10)</td></tr><tr><td align="center" valign="middle" >Double J drainage</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >38 (100)</td><td align="center" valign="middle" >24 (100)</td><td align="center" valign="middle" >62 (100)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Complications</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >35 (92.11)</td><td align="center" valign="middle" >24 (100)</td><td align="center" valign="middle" >59 (95.16)</td></tr><tr><td align="center" valign="middle" >Colic</td><td align="center" valign="middle" >2 (3.23)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >2 (3.23)</td></tr><tr><td align="center" valign="middle" >Fistula</td><td align="center" valign="middle" >1 (1.61)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >1 (1.61)</td></tr><tr><td align="center" valign="middle" >Median duration of surgery (minutes)</td><td align="center" valign="middle" >100 [90 - 120]</td><td align="center" valign="middle" >95 [80 - 120]</td><td align="center" valign="middle" >100 [90 - 120]</td></tr><tr><td align="center" valign="middle" >Mean duration of hospitalization (days)</td><td align="center" valign="middle" >2.29 &#177; 1.14</td><td align="center" valign="middle" >2.08 &#177; 0.97</td><td align="center" valign="middle" >2.21 &#177; 1.07</td></tr><tr><td align="center" valign="middle" >Median estimated blood loss (ml)</td><td align="center" valign="middle" >110 [80 - 150]</td><td align="center" valign="middle" >110 [82.5 - 145]</td><td align="center" valign="middle" >110 [80 - 150]</td></tr><tr><td align="center" valign="middle" >Median duration of double J stent in the body (days)</td><td align="center" valign="middle" >18 [15 - 21]</td><td align="center" valign="middle" >18 [16.5 - 21]</td><td align="center" valign="middle" >18 [15 - 21]</td></tr><tr><td align="center" valign="middle" >Duration of the drain in the body</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Day 0</td><td align="center" valign="middle" >32 (84.21)</td><td align="center" valign="middle" >23 (95.83)</td><td align="center" valign="middle" >55 (88.71)</td></tr><tr><td align="center" valign="middle" >Day 1</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >1 (1.61)</td></tr><tr><td align="center" valign="middle" >Day 2</td><td align="center" valign="middle" >4 (10.53)</td><td align="center" valign="middle" >2 (4.17)</td><td align="center" valign="middle" >5 (8.06)</td></tr><tr><td align="center" valign="middle" >Day 3</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >1 (1.61)</td></tr></tbody></table></table-wrap><p>Streptococcus pyogenes in 2 (3.23%) cases.</p><p>The serum creatinine levels of the participants ranged from 7 mg/L to 37 mg/L, with a median value of 10 [9 - 12] mg/L. The results of the paraclinical workup are presented in <xref ref-type="table" rid="table3">Table 3</xref>.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Paraclinical parameters of the study participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >VARIABLES</th><th align="center" valign="middle" >MALES (%)</th><th align="center" valign="middle" >FEMALES (%)</th><th align="center" valign="middle" >TOTAL (%)</th></tr></thead><tr><td align="center" valign="middle" >Stone size (mm)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >16 (42.11)</td><td align="center" valign="middle" >9 (37.5)</td><td align="center" valign="middle" >25 (40.32)</td></tr><tr><td align="center" valign="middle" >20 - 29</td><td align="center" valign="middle" >17 (44.73)</td><td align="center" valign="middle" >7 (29.17)</td><td align="center" valign="middle" >24 (38.71)</td></tr><tr><td align="center" valign="middle" >≥30</td><td align="center" valign="middle" >5 (13.16)</td><td align="center" valign="middle" >8 (33.33)</td><td align="center" valign="middle" >13 (20.97)</td></tr><tr><td align="center" valign="middle" >Urinalysis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >4 (10.53)</td><td align="center" valign="middle" >1 (4.17)</td><td align="center" valign="middle" >5 (8.06)</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >34 (89.47)</td><td align="center" valign="middle" >23 (95.83)</td><td align="center" valign="middle" >57 (91.94)</td></tr><tr><td align="center" valign="middle" >Culprit pathogen</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >34 (89.47)</td><td align="center" valign="middle" >23 (95.83)</td><td align="center" valign="middle" >57 (91.94)</td></tr><tr><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >1 (1.61)</td></tr><tr><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >1 (1.61)</td></tr><tr><td align="center" valign="middle" >Proteus mirabilis</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >1 (1.61)</td></tr><tr><td align="center" valign="middle" >Streptococcus pyogenes</td><td align="center" valign="middle" >1 (2.63)</td><td align="center" valign="middle" >1 (4.17)</td><td align="center" valign="middle" >2 (3.23)</td></tr><tr><td align="center" valign="middle" >Median serum creatinine (mg/L)</td><td align="center" valign="middle" >10 [9 - 12]</td><td align="center" valign="middle" >10 [9 - 11.5]</td><td align="center" valign="middle" >10 [9 - 12]</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Renal and ureteric stones are generally managed by URS, ESWL, PCNL, robotic surgery, and laparoscopic techniques. Laparoscopic techniques such as laparoscopic pyelolithotomy and laparoscopic ureterotomy are usually considered in patients who have renal anomalies, are poorly compliant, and have a large single renal-pelvic calculus [<xref ref-type="bibr" rid="scirp.114808-ref3">3</xref>]. The current study shows our experience in the management of 62 patients with renal calculi using laparoscopic pyelolithotomy.</p><p>A meta-analysis assessing the efficacy and safety of LPL versus percutaneous nephrolithotomy (PCNL) for the treatment of renal pelvic calculi &gt; 20 mm revealed that LPL is associated with a significantly higher stone-free rate than PCNL [<xref ref-type="bibr" rid="scirp.114808-ref9">9</xref>]. Al-Hunayan et al. compared the outcome of LPL using the transperitoneal approach to that using the retroperitoneal approach and found out that compared to transperitoneal LPL, retroperitoneal LPL for large renal pelvic stones resulted in a shorter operative time, a shorter resumption time for normal oral intake, and a shorter hospital stay. There was no significant difference in the stone-free rate between the two approaches [<xref ref-type="bibr" rid="scirp.114808-ref10">10</xref>]. In our study, patients were treated using the transperitoneal approach as we were more familiar with this approach and have had few complications using it in the past.</p><p>In the present study, we obtained a stone-free rate of 100% irrespective of the size and laterality of the stones. This success rate was higher than the 88.9% reported by Al-Hunayan et al. when 27 patients with renal calculi were managed using transperitoneal LPL [<xref ref-type="bibr" rid="scirp.114808-ref10">10</xref>].</p><p>In our study, the mean operative time was 100 minutes (Range: 90 - 120 minutes), which was similar to 80 - 150 min mean operative time reported by Mujeeburahimanet al. [<xref ref-type="bibr" rid="scirp.114808-ref11">11</xref>]. We experienced a median blood loss of 110 ml. This was higher than the &lt; 50 ml experienced by Mujeeburahiman et al. [<xref ref-type="bibr" rid="scirp.114808-ref11">11</xref>]. The mean hospital study in our study was 2.2 days, which was shorter than the 4 days reported by Nouralizadeh et al. who presented the efficacy and possible adverse complications of LPL for the treatment of staghorn stones as an alternative to percutaneous PCNL in a single-surgeon series [<xref ref-type="bibr" rid="scirp.114808-ref12">12</xref>]. This difference could be explained by the relatively low complication rate (4.84%) in the current study. Two (3.23%) patients experienced post-operative colic while 1 (1.61%) patient developed a fistula as a complication of the intervention. Previous studies have reported complications of laparoscopic pyelolithotomy including prolonged ileus, urinary tract infection, urinary obstruction, urinary leakage, and peritonitis [<xref ref-type="bibr" rid="scirp.114808-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.114808-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.114808-ref13">13</xref>]. This study showed that LPL has a high success rate in clearing large (&gt;20 mm) renal calculi and can be performed with minimal complications.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Laparoscopic removal of renal and ureteral calculi plays a role in special cases of urolithiasis. Laparoscopic pyelolithotomy provides an innovative and efficient technique for managing calculi of the renal pelvis, especially those with sizes greater than 20 mm. In experienced hands, it can be performed safely; therefore, it could replace open surgery. The benefits of laparoscopic surgery include lower postoperative morbidity, shorter hospitalization, shorter convalescence time, and better cosmetics results.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors thank Health Search Association for critically reviewing the manuscript.</p></sec><sec id="s7"><title>Availability of Data and Materials</title><p>The data analyzed in this study are available from the corresponding author upon reasonable request.</p></sec><sec id="s8"><title>Ethics Statement</title><p>Ethical approval was obtained from the institutional review board of the Faculty of Medicine and Pharmaceutical Sciences and the ethics committee of the Centre medico-chirugicaled’urologie in Douala, Cameroon. The requirement for informed consent was waived due to the retrospective nature of the study.</p></sec><sec id="s9"><title>Conflict of Interest Statement</title><p>The authors have no conflicting interests to declare.</p></sec><sec id="s10"><title>Cite this paper</title><p>Kamadjou, C., Kameni, A., Kolela, D.B., Ngninkeu, B.N. and Angwafor, F. (2022) Laparoscopic Pye- lolithotomy: Initial Experience with 62 Patients. Open Journal of Urology, 12, 74-82. https://doi.org/10.4236/oju.2022.121008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.114808-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Assimos, D., Krambeck, A., Miller, N.L., Monga, M., Murad, M.H., Nelson, C.P., et al. (2016) Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. The Journal of Urology, 196, 1153-1160. https://doi.org/10.1016/j.juro.2016.05.090</mixed-citation></ref><ref id="scirp.114808-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bai, Y., Tang, Y., Deng, L., et al. (2017) Management of Large Renal Stones: Laparoscopic Pyelolithotomy versus Percutaneous Nephrolithotomy. BMC Urology, 17, Article No. 75. https://doi.org/10.1186/s12894-017-0266-7</mixed-citation></ref><ref id="scirp.114808-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X., Li, S., Liu, T., et al. (2013) Laparoscopic Pyelolithotomy Compared to Percutaneous Nephrolithotomy as Surgical Management for Large Renal Pelvic calculi: A Meta-Analysis. Journal of Urology, 190, 888-893. https://doi.org/10.1016/j.juro.2013.02.092</mixed-citation></ref><ref id="scirp.114808-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shah</surname><given-names> S.R. </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Modified Method for Closure of Transverse Pyelotomy Incision in Gil-Vernet Pyelolithotomy Operation</article-title><source> Techniques in Urology</source><volume> 5</volume>,<fpage> 106</fpage>-<lpage>107</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.114808-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Salvadó, J.A., Guzmán, S., Trucco, C.A., et al. (2009) Laparoscopic Pyelolithotomy: Optimizing Surgical Technique. Journal of Endourology, 23, 575-578. https://doi.org/10.1089/end.2008.0582</mixed-citation></ref><ref id="scirp.114808-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Stein, R.J., Turna, B., Nguyen, M.M., et al. (2008) Laparoscopic Pyeloplasty with Concomitant Pyelolithotomy: Technique and Outcomes. Journal of Endourology, 22, 1251-1256. https://doi.org/10.1089/end.2008.0003</mixed-citation></ref><ref id="scirp.114808-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Meria, P., Milcent, S., Desgrandchamps, F., et al. (2005) Management of Pelvic Stones Larger than 20 mm: Laparoscopic Transperitoneal Pyelolithotomy or Percutaneous Nephrolithotomy? Urologia Internationalis, 75, 322-326. https://doi.org/10.1159/000089167</mixed-citation></ref><ref id="scirp.114808-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Chiva Robles, V., Escalera Almendros, C., Pascual Mateo, C., Rodríguez García, N., García Tello, A. and Berenguer Sánchez, A. (2006) Laparoscopic Pyelolithotomy. Archivos Espa&amp;#241;oles de Urología, 59, 175-178. https://doi.org/10.4321/S0004-06142006000200008</mixed-citation></ref><ref id="scirp.114808-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wang, J., Yang, Y., Chen, M., et al. (2016) Laparoscopic Pyelolithotomy versus Percutaneous Nephrolithotomy for Treatment of Large Renal Pelvic Calculi (Diameter &gt; 2 cm): A Meta-Analysis. Acta Chirurgica Belgica, 116, 346-356. https://doi.org/10.1080/00015458.2016.1181312</mixed-citation></ref><ref id="scirp.114808-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Al-Hunayan, A., Abdulhalim, H., El-Bakry, E., et al. (2009) Laparoscopic Pyelolithotomy: Is the Retroperitoneal Route a Better Approach? International Journal of Urology, 16, 181-186. https://doi.org/10.1111/j.1442-2042.2008.02210.x</mixed-citation></ref><ref id="scirp.114808-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mujeeburahiman, M. and Vipin, C. (2018) Laparoscopic Pyelolithotomy as a Monotherapy for the Management of Intermediate-Sized Renal Pelvic Stones. Urology Annals, 10, 254-257. https://doi.org/10.4103/UA.UA_80_17</mixed-citation></ref><ref id="scirp.114808-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Nouralizadeh, A., Simforoosh, N., Soltani, M.H., et al. (2012) Laparoscopic Transperitoneal Pyelolithotomy for Management of Staghorn Renal Calculi. Journal of Laparoendoscopic &amp; Advanced Surgical Techniques, 22, 61-65. https://doi.org/10.1089/lap.2011.0302</mixed-citation></ref><ref id="scirp.114808-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Nambirajan, T., Jeschke, S., Albqami, N., et al. (2005) Role of Laparoscopy in Management of Renal Stones: Single-Center Experience and Review of Literature. Journal of Endourology, 19, 353-359. https://doi.org/10.1089/end.2005.19.353</mixed-citation></ref></ref-list></back></article>